D. Tondi

Publications100
h-index18
Citations888
Highly Influential Citations14
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • B. Shoichet
  • 289 Publications • 30,374 Citations
  • R. Bonomo
  • 650 Publications • 29,493 Citations
  • Jean-Denis Docquier
  • 82 Publications • 2,952 Citations
  • P. Bellio
  • 44 Publications • 303 Citations
  • Publications
  • Influence
Structure-based design of inhibitors specific for bacterial thymidylate synthase.
Thymidylate synthase is an attractive target for antiproliferative drug design because of its key role in the synthesis of DNA. As such, the enzyme has been widely targeted for anticancer… Expand
  • 45
  • 3
  • PDF
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase
Human thymidylate synthase is a homodimeric enzyme that plays a key role in DNA synthesis and is a target for several clinically important anticancer drugs that bind to its active site. We have… Expand
  • 67
  • 3
  • PDF
Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-β-lactamase-1.
Bacterial resistance has become a worldwide concern after the emergence of metallo-β-lactamases (MBLs). They represent one of the major mechanisms of bacterial resistance against beta-lactam… Expand
  • 21
  • 2
Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase.
BACKGROUND The substrate sites of enzymes are attractive targets for structure-based inhibitor design. Two difficulties hinder efforts to discover and elaborate new (nonsubstrate-like) inhibitors for… Expand
  • 85
  • 1
Thymidylate synthase structure, function and implication in drug discovery.
Recent methodologies applied to the drug discovery process, such as genomics and proteomics, have greatly implemented our basic understanding of drug action and are giving more input to medicinal… Expand
  • 90
  • 1
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized the past decade, endangering… Expand
  • 32
  • 1
The inhibition of extended spectrum β-lactamases: hits and leads.
The ongoing emergence of bacterial strains resistant to even third- and fourth-generation β-lactam antibiotics is one of the most pressing and challenging issues in clinical therapy. Furthermore,… Expand
  • 20
  • 1
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases
Abstractβ-Lactamases (BLs) able to hydrolyze β-lactam antibiotics and more importantly the last resort carbapenems, represent a major mechanism of resistance in Gram-negative bacteria showing… Expand
  • 17
  • 1
  • PDF
In silico identification and experimental validation of hits active against KPC-2 β-lactamase
Bacterial resistance has become a worldwide concern, particularly after the emergence of resistant strains overproducing carbapenemases. Among these, the KPC-2 carbapenemase represents a significant… Expand
  • 6
  • 1
  • PDF
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
A series of 3,8-diazabicyclo[3.2.1]octanes substituted either at the 3 position (compounds 1) or at the 8 position (compounds 2) by a chlorinated heteroaryl ring were synthesized, as potential… Expand
  • 48
...
1
2
3
4
5
...